AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

PROTEOMICS INTERNATIONAL LAB

0.455

-0.010-2.15%

Volume:77.43K

Turnover:35.79K

Market Cap:75.13M

PE:-7.53

High:0.470

Open:0.470

Low:0.455

Close:0.465

52wk High:0.860

52wk Low:0.285

Shares:165.12M

Float Shares:121.55M

Volume Ratio:0.21

T/O Rate:0.06%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.060

EPS(LYR):-0.060

ROE:-73.41%

ROA:-40.28%

PB:5.70

PE(LYR):-7.53

Loading ...

Overview Company News Filings

Proteomics International Laboratories (ASX:PIQ) adds AU$22m to market cap in the past 7 days, though investors from three years ago are still down 28%

Simply Wall St.

BRIEF-Proteomics International Laboratories Says Canadian Patent Secured For Promarkereso Diagnostic Test For Esophageal Adenocarcinoma

Proteomics Receives Canadian Patent for Esophageal Cancer Blood Test

MT Newswires Live

BRIEF-Proteomics International Laboratories Ltd-Appointment Of CEO And Managing Director

Proteomics International Laboratories Appoints CEO

MT Newswires Live

Proteomics International Laboratories Ltd-Appointment of CEO and Managing Director

THOMSON REUTERS

Proteomics International Says US Reference Lab Accredited by CAP

MT Newswires Live

BRIEF-Proteomics International Laboratories Says US Patent Secured For Promarkereso Diagnostic Test

BUZZ-Proteomics at 9-month high on securing US patent for diagnostic test

Proteomics International Laboratories - US Patent Secured for Promarkereso Diagnostic Test for Esophageal Adenocarcinoma

THOMSON REUTERS

Proteomics International Laboratories Ltd-Promarkerd Changes How Doctors Manage Dkd - Study Published

THOMSON REUTERS

Proteomics Says Blood Test Shows 'Promising' Prognostic Accuracy for Diabetic Kidney Disease in Aboriginals

MT Newswires Live

We're Not Very Worried About Proteomics International Laboratories' (ASX:PIQ) Cash Burn Rate

Simply Wall St.

Proteomics Says US CMS Sets Reimbursement Price for Kidney Disease Predictive Test; Shares Rise 16%

MT Newswires Live

Proteomics Says Racehorse Performance Data Confirms Potential of Unit's Stress Testing Technology; Shares Jump 5%

MT Newswires Live

BRIEF-Proteomics International Laboratories Receives A$2.2M In Research And Development Tax Incentive

Proteomics International Laboratories - All Figures in AUD

THOMSON REUTERS

Proteomics International Laboratories Ltd-Proteomics International Receives $2.2M in R&D Tax Incentive

THOMSON REUTERS

Proteomics International Receives AU$500,000 Western Australia Grant to Help Commercialize Endometriosis Blood Test

MT Newswires Live

Proteomics International Laboratories Ltd - All Figures in AUD

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/PIQ.AU/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"PIQ.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"PIQ.AU\",,,,,undefined,":{"symbol":"PIQ.AU","market":"AU","secType":"STK","nameCN":"PROTEOMICS INTERNATIONAL LAB","latestPrice":0.455,"timestamp":1770700320000,"preClose":0.465,"halted":0,"volume":77429,"delay":0,"changeRate":-0.02150537634408604,"nameEN":"PROTEOMICS INTERNATIONAL LAB","floatShares":121549097,"shares":165116433,"eps":-0.060439,"marketStatus":"Closed","change":-0.01,"latestTime":"02-10 16:12:00 AEDT","open":0.47,"high":0.47,"low":0.455,"amount":35785,"amplitude":0.032258,"askPrice":0.46,"askSize":141081,"bidPrice":0.455,"bidSize":14789,"shortable":3,"etf":0,"ttmEps":-0.060439,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1770764400000},"marketStatusCode":5,"adr":0,"exchange":"ASX","adjPreClose":0.465,"openAndCloseTimeList":[[1770678000000,1770699600000]],"volumeRatio":0.214558,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"PIQ.AU\",,,,,undefined,":{"symbol":"PIQ.AU","floatShares":121549097,"roa":"-40.28%","roe":"-73.41%","lyrEps":-0.060439,"volumeRatio":0.214558,"shares":165116433,"dividePrice":0,"high":0.47,"amplitude":0.032258,"preClose":0.465,"low":0.455,"week52Low":0.285,"pbRate":"5.70","psRate":"22.68","week52High":0.86,"institutionHeld":0,"latestPrice":0.455,"committee":-0.810239,"eps":-0.060439,"divideRate":0,"volume":77429,"delay":0,"ttmEps":-0.060439,"open":0.47,"prevYearClose":0.655,"prevWeekClose":0.45,"prevMonthClose":0.47,"prevQuarterClose":0.655,"fiveDayClose":0.5,"twentyDayClose":0.665,"sixtyDayClose":0.35},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PIQ.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PIQ.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PIQ.AU\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2604901421","title":"Proteomics International Laboratories (ASX:PIQ) adds AU$22m to market cap in the past 7 days, though investors from three years ago are still down 28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2604901421","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604901421?lang=en_us&edition=fundamental","pubTime":"2026-01-19 06:17","pubTimestamp":1768774657,"startTime":"0","endTime":"0","summary":"Proteomics International Laboratories Ltd ( ASX:PIQ ) shareholders will doubtless be very grateful to see the share...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-piq/proteomics-international-laboratories-shares/news/proteomics-international-laboratories-asxpiq-adds-au22m-to-m","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-piq/proteomics-international-laboratories-shares/news/proteomics-international-laboratories-asxpiq-adds-au22m-to-m","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["PIQ.AU","BK7508","BK7048"],"gpt_icon":0},{"id":"2603957615","title":"BRIEF-Proteomics International Laboratories Says Canadian Patent Secured For Promarkereso Diagnostic Test For Esophageal Adenocarcinoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2603957615","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603957615?lang=en_us&edition=fundamental","pubTime":"2026-01-16 14:42","pubTimestamp":1768545729,"startTime":"0","endTime":"0","summary":"BRIEF-Proteomics International Laboratories Says Canadian Patent Secured For Promarkereso Diagnostic Test For Esophageal AdenocarcinomaJan 16 (Reuters) - Proteomics International Laboratories Ltd PIQ.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260116:nFWN3YG0RE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PIQ.AU","BK7048","BK7508"],"gpt_icon":0},{"id":"2603693999","title":"Proteomics Receives Canadian Patent for Esophageal Cancer Blood Test","url":"https://stock-news.laohu8.com/highlight/detail?id=2603693999","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603693999?lang=en_us&edition=fundamental","pubTime":"2026-01-16 06:22","pubTimestamp":1768515750,"startTime":"0","endTime":"0","summary":"Proteomics International Laboratories  received a patent from the Canadian Patent Office for its PromarkerEso, a blood test to rule out esophageal cancer caused by chronic acid reflux in patients, according to a Friday Australian bourse filing.The granted patent provides intellectual property protection for PromarkerEso in Canada until Nov. 17, 2035, the filing said.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PIQ.AU","BK7508","BK7048"],"gpt_icon":0},{"id":"2603652974","title":"BRIEF-Proteomics International Laboratories Ltd-Appointment Of CEO And Managing Director","url":"https://stock-news.laohu8.com/highlight/detail?id=2603652974","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603652974?lang=en_us&edition=fundamental","pubTime":"2026-01-14 09:34","pubTimestamp":1768354490,"startTime":"0","endTime":"0","summary":"BRIEF-Proteomics International Laboratories Ltd-Appointment Of CEO And Managing DirectorJan 14  - Proteomics International Laboratories Ltd PIQ.AX:APPOINTMENT OF CEO AND MANAGING DIRECTORAPPOINTS DAVID MORRIS AS CEO & MDFurther company coverage: PIQ.AX ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260114:nTUE8NNHWS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PIQ.AU","BK7048","BK7508"],"gpt_icon":0},{"id":"2603653730","title":"Proteomics International Laboratories Appoints CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=2603653730","media":"MT Newswires Live","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603653730?lang=en_us&edition=fundamental","pubTime":"2026-01-14 06:12","pubTimestamp":1768342350,"startTime":"0","endTime":"0","summary":"Proteomics International Laboratories  appointed David Morris as chief executive, effective Jan. 19, according to a Wednesday Australian bourse filing.Morris will succeed Richard Lipscombe, who will continue to assist with the transition until his formal retirement on Feb. 23, the filing added.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7048","BK7508","PIQ.AU"],"gpt_icon":0},{"id":"2603653873","title":"Proteomics International Laboratories Ltd-Appointment of CEO and Managing Director","url":"https://stock-news.laohu8.com/highlight/detail?id=2603653873","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603653873?lang=en_us&edition=fundamental","pubTime":"2026-01-14 05:44","pubTimestamp":1768340669,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260113:nTUE8NNHWS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PIQ.AU","BK7048","BK7508"],"gpt_icon":0},{"id":"2593428282","title":"Proteomics International Says US Reference Lab Accredited by CAP","url":"https://stock-news.laohu8.com/highlight/detail?id=2593428282","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593428282?lang=en_us&edition=fundamental","pubTime":"2025-12-24 11:00","pubTimestamp":1766545221,"startTime":"0","endTime":"0","summary":"Proteomics International Laboratories  said its US reference laboratory in Irvine, California, received accreditation by the College of American Pathologists  based on the results of a recent on-site inspection, according to a Wednesday Australian bourse filing.It completed the installation of a new mass spectrometry platform. It is employing this platform to establish its PromarkerEso diagnostic test to detect esophageal adenocarcinoma. It plans to launch the test in the US in 2026.The firm's shares climbed 1% in recent trading on Wednesday.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CAP.AU","BK7048","BK7508","PIQ.AU"],"gpt_icon":0},{"id":"2592951467","title":"BRIEF-Proteomics International Laboratories Says US Patent Secured For Promarkereso Diagnostic Test","url":"https://stock-news.laohu8.com/highlight/detail?id=2592951467","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592951467?lang=en_us&edition=fundamental","pubTime":"2025-12-17 09:17","pubTimestamp":1765934265,"startTime":"0","endTime":"0","summary":"BRIEF-Proteomics International Laboratories Says US Patent Secured For Promarkereso Diagnostic TestDec 17 (Reuters) - Proteomics International Laboratories Ltd PIQ.AX:US PATENT SECURED FOR PROMARKERES","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251217:nFWN3XM0LD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PIQ.AU","BK7508","BK7048"],"gpt_icon":0},{"id":"2592563099","title":"BUZZ-Proteomics at 9-month high on securing US patent for diagnostic test","url":"https://stock-news.laohu8.com/highlight/detail?id=2592563099","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592563099?lang=en_us&edition=fundamental","pubTime":"2025-12-17 08:13","pubTimestamp":1765930380,"startTime":"0","endTime":"0","summary":"BUZZ-Proteomics at 9-month high on securing US patent for diagnostic test** Shares of Australia's Proteomics International Laboratories PIQ.AX rise as much as 7.6% to A$0.570, their highest level since late-February** Medical technology firm secures U.S. patent for PromarkerEso diagnostic testfor early diagnosis of esophageal cancer** Stock is down 28.8% YTD,  including the session's moves","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251217:nL6N3XN00E:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PIQ.AU","BK7508","BK7048"],"gpt_icon":0},{"id":"2592504930","title":"Proteomics International Laboratories - US Patent Secured for Promarkereso Diagnostic Test for Esophageal Adenocarcinoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2592504930","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592504930?lang=en_us&edition=fundamental","pubTime":"2025-12-17 05:33","pubTimestamp":1765920838,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251216:nFWN3XM0LD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","BK7048","PIQ.AU"],"gpt_icon":0},{"id":"2591462237","title":"Proteomics International Laboratories Ltd-Promarkerd Changes How Doctors Manage Dkd - Study Published","url":"https://stock-news.laohu8.com/highlight/detail?id=2591462237","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591462237?lang=en_us&edition=fundamental","pubTime":"2025-12-16 05:46","pubTimestamp":1765835161,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251215:nTUE8GR1JW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PIQ.AU","BK7048","BK7508"],"gpt_icon":0},{"id":"2591694515","title":"Proteomics Says Blood Test Shows 'Promising' Prognostic Accuracy for Diabetic Kidney Disease in Aboriginals","url":"https://stock-news.laohu8.com/highlight/detail?id=2591694515","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591694515?lang=en_us&edition=fundamental","pubTime":"2025-12-15 11:50","pubTimestamp":1765770622,"startTime":"0","endTime":"0","summary":"Proteomics International Laboratories  said its PromarkerD predictive blood test has the potential to support earlier, more accurate identification of kidney disease risk in Aboriginal Australians with type 2 diabetes, according to a Monday filing with the Australian bourse.The test delivered a 'rule out' rate of over 85% in Aboriginal participants, showing that a low score can reliably identify individuals unlikely to experience near-term kidney function decline.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7048","BK7508","PIQ.AU"],"gpt_icon":0},{"id":"2586299927","title":"We're Not Very Worried About Proteomics International Laboratories' (ASX:PIQ) Cash Burn Rate","url":"https://stock-news.laohu8.com/highlight/detail?id=2586299927","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586299927?lang=en_us&edition=fundamental","pubTime":"2025-11-27 07:52","pubTimestamp":1764201165,"startTime":"0","endTime":"0","summary":"Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice1-main-header/1585186657000"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-piq/proteomics-international-laboratories-shares/news/were-not-very-worried-about-proteomics-international-laborat","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-piq/proteomics-international-laboratories-shares/news/were-not-very-worried-about-proteomics-international-laborat","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7048","BK7508","PIQ.AU"],"gpt_icon":0},{"id":"2586528032","title":"Proteomics Says US CMS Sets Reimbursement Price for Kidney Disease Predictive Test; Shares Rise 16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586528032","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586528032?lang=en_us&edition=fundamental","pubTime":"2025-11-26 13:00","pubTimestamp":1764133200,"startTime":"0","endTime":"0","summary":"Proteomics International Laboratories  said the US Centers for Medicare & Medicaid Services set a reimbursement price of $390.75 for Promarker D, the company's predictive test for diabetic kidney disease, effective Jan.1, 2026, according to a Wednesday filing with the Australian bourse.The company will now seek to obtain private health insurer coverage, the filing said.Shares of the company rose 16% in recent Wednesday trade.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK7048","LU2346227817.USD","LU0949170772.SGD","CMS","LU2500361329.USD","LU1003077747.HKD","PIQ.AU","LU0738911758.USD","BK4208","BK4585","LU1894683264.USD","LU0553294199.USD","LU0661504455.SGD","BK7508","LU0545039389.USD","LU2637428348.USD","LU1894683348.USD","BK4588"],"gpt_icon":0},{"id":"2585437143","title":"Proteomics Says Racehorse Performance Data Confirms Potential of Unit's Stress Testing Technology; Shares Jump 5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2585437143","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585437143?lang=en_us&edition=fundamental","pubTime":"2025-11-24 11:47","pubTimestamp":1763956054,"startTime":"0","endTime":"0","summary":"Proteomics International Laboratories  said performance data on Australian thoroughbred racehorses supports the potential of its OxiDx unit's oxidative stress testing technology in providing insight into the physiological readiness of racehorses, according to a Monday filing with the Australian bourse.New findings gathered using the OxiDx test showed that thoroughbred horses racing without oxidative stress were 76% more likely to place and 49% more likely to win than horses with oxidative stress, the filing said.Horses racing without oxidative stress increased the likelihood of winning or placing in the top three, the filing added.Shares of the company rose 5% in recent Monday trade.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["XJO.AU","PIQ.AU","XAO.AU","XKO.AU","BK7508","BK7048"],"gpt_icon":0},{"id":"2582314475","title":"BRIEF-Proteomics International Laboratories Receives A$2.2M In Research And Development Tax Incentive","url":"https://stock-news.laohu8.com/highlight/detail?id=2582314475","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582314475?lang=en_us&edition=fundamental","pubTime":"2025-11-12 09:21","pubTimestamp":1762910506,"startTime":"0","endTime":"0","summary":"BRIEF-Proteomics International Laboratories Receives A$2.2M In Research And Development Tax IncentiveNov 12  - Proteomics International Laboratories Ltd PIQ.AX:PROTEOMICS INTERNATIONAL RECEIVES A$2.2M IN RESEARCH AND DEVELOPMENT TAX INCENTIVEFurther company coverage: PIQ.AX ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251112:nTUE5YB9L6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PIQ.AU","BK7508","BK7048"],"gpt_icon":0},{"id":"2582318575","title":"Proteomics International Laboratories -  All Figures in AUD","url":"https://stock-news.laohu8.com/highlight/detail?id=2582318575","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582318575?lang=en_us&edition=fundamental","pubTime":"2025-11-12 06:04","pubTimestamp":1762898668,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251111:nTUE5YB9L6:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PIQ.AU","BK7508","BK7048"],"gpt_icon":0},{"id":"2582185273","title":"Proteomics International Laboratories Ltd-Proteomics International Receives $2.2M in R&D Tax Incentive","url":"https://stock-news.laohu8.com/highlight/detail?id=2582185273","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582185273?lang=en_us&edition=fundamental","pubTime":"2025-11-12 06:04","pubTimestamp":1762898668,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251111:nTUE5YB9L6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","PIQ.AU","BK7048"],"gpt_icon":0},{"id":"2581003705","title":"Proteomics International Receives AU$500,000 Western Australia Grant to Help Commercialize Endometriosis Blood Test","url":"https://stock-news.laohu8.com/highlight/detail?id=2581003705","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581003705?lang=en_us&edition=fundamental","pubTime":"2025-11-06 14:29","pubTimestamp":1762410577,"startTime":"0","endTime":"0","summary":"Proteomics International Laboratories  received a AU$500,000 grant from the Western Australian government to accelerate the commercialization of its blood test for the early diagnosis of endometriosis, according to a Thursday Australian bourse filing.The funding was provided by the Western Australian government's Future Health Research and Innovation Fund. It will contribute to commercialization activities, including regulatory engagement, marketing, and partnership development.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["PIQ.AU","WRN","XKO.AU","BK7508","BK7048","XAO.AU","XJO.AU","BK4168"],"gpt_icon":0},{"id":"2581033533","title":"Proteomics International Laboratories Ltd - All Figures in AUD","url":"https://stock-news.laohu8.com/highlight/detail?id=2581033533","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581033533?lang=en_us&edition=fundamental","pubTime":"2025-11-06 10:52","pubTimestamp":1762397523,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251106:nTUE2HYPVB:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7508","BK7048","PIQ.AU"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":28,"code":"91000000","status":"200"}]}}